カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のパクリタキセル薬剤溶出バルーン市場2023年：企業・地域・タイプ・用途別分析

◆英語タイトル：Global Paclitaxel Drug-Eluting Balloon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書（GIR23SM7444）◆商品コード：GIR23SM7444
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年9月
◆ページ数：105
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のパクリタキセル薬剤溶出バルーンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のパクリタキセル薬剤溶出バルーン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- パクリタキセル薬剤溶出バルーンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

パクリタキセル薬剤溶出バルーン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・バルーン・オンリーコーティング、薬剤コーティングバルーン

用途別セグメント
・末梢動脈疾患、冠動脈疾患

主要な市場プレーヤー
・Medtronic、Boston Scientific、B. Braun、Cook Medical、Cardionovum、Aachen Resonance、QT Vascular、Biotronic、Philips、Eurocor、Yinyi Biotech、Lepu Medical Technology

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、パクリタキセル薬剤溶出バルーン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なパクリタキセル薬剤溶出バルーンメーカーの企業概要、2019年～2022年までのパクリタキセル薬剤溶出バルーンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なパクリタキセル薬剤溶出バルーンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別パクリタキセル薬剤溶出バルーンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのパクリタキセル薬剤溶出バルーンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのパクリタキセル薬剤溶出バルーン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびパクリタキセル薬剤溶出バルーンの産業チェーンを掲載しています。
・第14、15章では、パクリタキセル薬剤溶出バルーンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– パクリタキセル薬剤溶出バルーンの概要
– タイプ別分析（2018年vs2022年vs2029年）：バルーン・オンリーコーティング、薬剤コーティングバルーン
– 用途別分析（2018年vs2022年vs2029年）：末梢動脈疾患、冠動脈疾患
– 世界のパクリタキセル薬剤溶出バルーン市場規模・予測
– 世界のパクリタキセル薬剤溶出バルーン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Medtronic、Boston Scientific、B. Braun、Cook Medical、Cardionovum、Aachen Resonance、QT Vascular、Biotronic、Philips、Eurocor、Yinyi Biotech、Lepu Medical Technology
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：バルーン・オンリーコーティング、薬剤コーティングバルーン
・用途別分析2018年-2029年：末梢動脈疾患、冠動脈疾患
・パクリタキセル薬剤溶出バルーンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・パクリタキセル薬剤溶出バルーンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・パクリタキセル薬剤溶出バルーンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・パクリタキセル薬剤溶出バルーンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・パクリタキセル薬剤溶出バルーンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Paclitaxel Drug-Eluting Balloon
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Balloon-Only Coating
1.3.3 Drug-Coated Balloon
1.4 Market Analysis by Application
1.4.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Peripheral Artery Disease
1.4.3 Coronary Artery Disease
1.5 Global Paclitaxel Drug-Eluting Balloon Market Size & Forecast
1.5.1 Global Paclitaxel Drug-Eluting Balloon Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Paclitaxel Drug-Eluting Balloon Sales Quantity (2018-2029)
1.5.3 Global Paclitaxel Drug-Eluting Balloon Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
2.1.4 Medtronic Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Recent Developments/Updates
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
2.2.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boston Scientific Recent Developments/Updates
2.3 B. Braun
2.3.1 B. Braun Details
2.3.2 B. Braun Major Business
2.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
2.3.4 B. Braun Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 B. Braun Recent Developments/Updates
2.4 Cook Medical
2.4.1 Cook Medical Details
2.4.2 Cook Medical Major Business
2.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Product and Services
2.4.4 Cook Medical Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cook Medical Recent Developments/Updates
2.5 Cardionovum
2.5.1 Cardionovum Details
2.5.2 Cardionovum Major Business
2.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Product and Services
2.5.4 Cardionovum Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cardionovum Recent Developments/Updates
2.6 Aachen Resonance
2.6.1 Aachen Resonance Details
2.6.2 Aachen Resonance Major Business
2.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product and Services
2.6.4 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aachen Resonance Recent Developments/Updates
2.7 QT Vascular
2.7.1 QT Vascular Details
2.7.2 QT Vascular Major Business
2.7.3 QT Vascular Paclitaxel Drug-Eluting Balloon Product and Services
2.7.4 QT Vascular Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 QT Vascular Recent Developments/Updates
2.8 Biotronic
2.8.1 Biotronic Details
2.8.2 Biotronic Major Business
2.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Product and Services
2.8.4 Biotronic Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biotronic Recent Developments/Updates
2.9 Philips
2.9.1 Philips Details
2.9.2 Philips Major Business
2.9.3 Philips Paclitaxel Drug-Eluting Balloon Product and Services
2.9.4 Philips Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Philips Recent Developments/Updates
2.10 Eurocor
2.10.1 Eurocor Details
2.10.2 Eurocor Major Business
2.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
2.10.4 Eurocor Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eurocor Recent Developments/Updates
2.11 Yinyi Biotech
2.11.1 Yinyi Biotech Details
2.11.2 Yinyi Biotech Major Business
2.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product and Services
2.11.4 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Yinyi Biotech Recent Developments/Updates
2.12 Lepu Medical Technology
2.12.1 Lepu Medical Technology Details
2.12.2 Lepu Medical Technology Major Business
2.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product and Services
2.12.4 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lepu Medical Technology Recent Developments/Updates
3 Competitive Environment: Paclitaxel Drug-Eluting Balloon by Manufacturer
3.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Manufacturer (2018-2023)
3.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Manufacturer (2018-2023)
3.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Paclitaxel Drug-Eluting Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2022
3.4.2 Top 6 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2022
3.5 Paclitaxel Drug-Eluting Balloon Market: Overall Company Footprint Analysis
3.5.1 Paclitaxel Drug-Eluting Balloon Market: Region Footprint
3.5.2 Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
3.5.3 Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Paclitaxel Drug-Eluting Balloon Market Size by Region
4.1.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2029)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2029)
4.1.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Region (2018-2029)
4.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.3 Europe Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.4 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.5 South America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
4.6 Middle East and Africa Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
5.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type (2018-2029)
5.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
6.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application (2018-2029)
6.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Application (2018-2029)
7 North America
7.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
7.2 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
7.3 North America Paclitaxel Drug-Eluting Balloon Market Size by Country
7.3.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
7.3.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
8.2 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
8.3 Europe Paclitaxel Drug-Eluting Balloon Market Size by Country
8.3.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
8.3.2 Europe Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Paclitaxel Drug-Eluting Balloon Market Size by Region
9.3.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
10.2 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
10.3 South America Paclitaxel Drug-Eluting Balloon Market Size by Country
10.3.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
10.3.2 South America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Market Size by Country
11.3.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Paclitaxel Drug-Eluting Balloon Market Drivers
12.2 Paclitaxel Drug-Eluting Balloon Market Restraints
12.3 Paclitaxel Drug-Eluting Balloon Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Paclitaxel Drug-Eluting Balloon and Key Manufacturers
13.2 Manufacturing Costs Percentage of Paclitaxel Drug-Eluting Balloon
13.3 Paclitaxel Drug-Eluting Balloon Production Process
13.4 Paclitaxel Drug-Eluting Balloon Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Paclitaxel Drug-Eluting Balloon Typical Distributors
14.3 Paclitaxel Drug-Eluting Balloon Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
Table 6. Medtronic Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Medtronic Recent Developments/Updates
Table 8. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Boston Scientific Major Business
Table 10. Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
Table 11. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boston Scientific Recent Developments/Updates
Table 13. B. Braun Basic Information, Manufacturing Base and Competitors
Table 14. B. Braun Major Business
Table 15. B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
Table 16. B. Braun Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. B. Braun Recent Developments/Updates
Table 18. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 19. Cook Medical Major Business
Table 20. Cook Medical Paclitaxel Drug-Eluting Balloon Product and Services
Table 21. Cook Medical Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Cook Medical Recent Developments/Updates
Table 23. Cardionovum Basic Information, Manufacturing Base and Competitors
Table 24. Cardionovum Major Business
Table 25. Cardionovum Paclitaxel Drug-Eluting Balloon Product and Services
Table 26. Cardionovum Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Cardionovum Recent Developments/Updates
Table 28. Aachen Resonance Basic Information, Manufacturing Base and Competitors
Table 29. Aachen Resonance Major Business
Table 30. Aachen Resonance Paclitaxel Drug-Eluting Balloon Product and Services
Table 31. Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Aachen Resonance Recent Developments/Updates
Table 33. QT Vascular Basic Information, Manufacturing Base and Competitors
Table 34. QT Vascular Major Business
Table 35. QT Vascular Paclitaxel Drug-Eluting Balloon Product and Services
Table 36. QT Vascular Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. QT Vascular Recent Developments/Updates
Table 38. Biotronic Basic Information, Manufacturing Base and Competitors
Table 39. Biotronic Major Business
Table 40. Biotronic Paclitaxel Drug-Eluting Balloon Product and Services
Table 41. Biotronic Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Biotronic Recent Developments/Updates
Table 43. Philips Basic Information, Manufacturing Base and Competitors
Table 44. Philips Major Business
Table 45. Philips Paclitaxel Drug-Eluting Balloon Product and Services
Table 46. Philips Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Philips Recent Developments/Updates
Table 48. Eurocor Basic Information, Manufacturing Base and Competitors
Table 49. Eurocor Major Business
Table 50. Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
Table 51. Eurocor Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Eurocor Recent Developments/Updates
Table 53. Yinyi Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Yinyi Biotech Major Business
Table 55. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product and Services
Table 56. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Yinyi Biotech Recent Developments/Updates
Table 58. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 59. Lepu Medical Technology Major Business
Table 60. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product and Services
Table 61. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Lepu Medical Technology Recent Developments/Updates
Table 63. Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Paclitaxel Drug-Eluting Balloon Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Paclitaxel Drug-Eluting Balloon, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Paclitaxel Drug-Eluting Balloon Production Site of Key Manufacturer
Table 68. Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
Table 69. Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
Table 70. Paclitaxel Drug-Eluting Balloon New Market Entrants and Barriers to Market Entry
Table 71. Paclitaxel Drug-Eluting Balloon Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Paclitaxel Drug-Eluting Balloon Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Paclitaxel Drug-Eluting Balloon Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Paclitaxel Drug-Eluting Balloon Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Paclitaxel Drug-Eluting Balloon Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Paclitaxel Drug-Eluting Balloon Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Paclitaxel Drug-Eluting Balloon Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Paclitaxel Drug-Eluting Balloon Raw Material
Table 131. Key Manufacturers of Paclitaxel Drug-Eluting Balloon Raw Materials
Table 132. Paclitaxel Drug-Eluting Balloon Typical Distributors
Table 133. Paclitaxel Drug-Eluting Balloon Typical Customers
List of Figures
Figure 1. Paclitaxel Drug-Eluting Balloon Picture
Figure 2. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Type in 2022
Figure 4. Balloon-Only Coating Examples
Figure 5. Drug-Coated Balloon Examples
Figure 6. Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Application in 2022
Figure 8. Peripheral Artery Disease Examples
Figure 9. Coronary Artery Disease Examples
Figure 10. Global Paclitaxel Drug-Eluting Balloon Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Paclitaxel Drug-Eluting Balloon Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Paclitaxel Drug-Eluting Balloon Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Paclitaxel Drug-Eluting Balloon Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Paclitaxel Drug-Eluting Balloon by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Paclitaxel Drug-Eluting Balloon Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Paclitaxel Drug-Eluting Balloon Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Paclitaxel Drug-Eluting Balloon Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Paclitaxel Drug-Eluting Balloon Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Region (2018-2029)
Figure 52. China Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Paclitaxel Drug-Eluting Balloon Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Paclitaxel Drug-Eluting Balloon Market Drivers
Figure 73. Paclitaxel Drug-Eluting Balloon Market Restraints
Figure 74. Paclitaxel Drug-Eluting Balloon Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon in 2022
Figure 77. Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
Figure 78. Paclitaxel Drug-Eluting Balloon Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のパクリタキセル薬剤溶出バルーン市場2023年：企業・地域・タイプ・用途別分析(Global Paclitaxel Drug-Eluting Balloon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 薬剤溶出バルーンカテーテルの世界市場2022年～2029年：薬剤別、疾患別、エンドユーザー別、地域別
  • 冠動脈疾患用薬剤溶出バルーンの世界市場見通し2023年-2029年
  • 世界の心血管薬剤溶出ステント（DES）市場2023年：企業・地域・タイプ・用途別分析
  • 薬剤溶出バルーンカテーテルの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆